NPPB and heart failure: BAT was initially developed as a treatment for angina pectoris and hypertension, but it has been reported that NT-proBNP is lowered and exercise tolerance is improved for heart failure with reduced ejection fraction (Abraham et al., 2015; Schmidt et al., 2020).